PRESS DIGEST- Financial Times - June 28
June 28 The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Feb 16 Global Blood Therapeutics Inc :
* Global Blood Therapeutics announces initiation of phase 1 trial to evaluate the physiologic effects of gbt440 in healthy volunteers under hypoxemic conditions
* Global Blood Therapeutics -currently conducting 2 phase 2a clinical trials of gbt440 as potential treatment for hypoxemia in 2 groups of hypoxemic ipf patients Source text for Eikon: Further company coverage:
WASHINGTON, June 27 Senate Republican leader Mitch McConnell on Tuesday said a meeting between Senate Republicans and President Donald Trump on healthcare was helpful and he expressed optimism the Senate would eventually pass a bill to repeal Obamacare.
OTTAWA, June 27 Canada's Competition Bureau said on Tuesday it would allow a planned merger between DuPont and Dow Chemical Co after both firms agreed to dispose of some assets.